Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. - Wikidata - awgldk - TriplyDB

Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.

Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.

http://www.wikidata.org/entity/Q34078570

about

Regulation of peripheral metabolism by substrate partitioning in the brain.Carcinoembryonic antigen-related cell adhesion molecule 2 controls energy balance and peripheral insulin action in mice PGRN induces impaired insulin sensitivity and defective autophagy in hepatic insulin resistance Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism.Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene.The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis.Anti-Obesity and Anti-Diabetic Effects of Acacia Polyphenol in Obese Diabetic KKAy Mice Fed High-Fat Diet.Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis.Sense and nonsense in metabolic control of reproduction AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity.Administration of progranulin (PGRN) triggers ER stress and impairs insulin sensitivity via PERK-eIF2α-dependent manner.Regulation of hypothalamic malonyl-CoA by central glucose and leptin.Effects of Ghrelin on Triglyceride Accumulation and Glucose Uptake in Primary Cultured Rat Myoblasts under Palmitic Acid-Induced High Fat Conditions AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.Intraperitoneal injections of low doses of C75 elicit a behaviorally specific and vagal afferent-independent inhibition of eating in rats.Natural compounds as regulators of the cancer cell metabolism Leptin Resistance Contributes to Obesity in Mice with Null Mutation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1.Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism.Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice.Hypothalamic malonyl-coenzyme A and the control of energy balance.Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation Neural control of the anorexia-cachexia syndrome.Brain-specific carnitine palmitoyl-transferase-1c: role in CNS fatty acid metabolism, food intake, and body weight Hypothalamic malonyl-CoA and CPT1c in the treatment of obesity.Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs.Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight.Eat and Death: Chronic Over-Eating.Influence of dietary fats on Ecstasy-induced hyperthermia Carnitine palmitoyltransferase-1c gain-of-function in the brain results in postnatal microencephaly.The central administration of C75, a fatty acid synthase inhibitor, activates sympathetic outflow and thermogenesis in interscapular brown adipose tissue.Effect of fluoxetine treatment on mitochondrial bioenergetics in central and peripheral rat tissues.A role for hypothalamic malonyl-CoA in the control of food intake.Intracerebroventricular C75 decreases meal frequency and reduces AgRP gene expression in rats.Improvement of diabetic or obese patients' erythrocyte deformability by the program of the brain-oriented obesity control system (BOOCS).Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis

P2860

Q27692584-49C16740-D0D9-40DF-BB79-81CFFA33528C Q28513543-421E34F6-E3E7-41BC-A01C-9A679A4B2620 Q33631744-7A7BFDF2-E665-4AC5-98E5-3C2B91AC1DE8 Q34058540-FC3A28EA-2F4B-4191-8F67-0326AB377112 Q34387949-43AD270B-3EAA-4DA7-A377-B1B8F34C611F Q34603754-8406691C-FA54-4396-8B95-CF895452D4F6 Q35016478-EEF1AB68-6E6F-4B9B-9B2D-FD6E17A84268 Q35025300-43C0E26D-FEFA-408A-A59B-6E87960275E7 Q35109666-9D8A68D5-CC1C-4053-B273-D0801873F40A Q35921527-44653F05-39FB-46AE-8C6E-0FDE93BFE17C Q35971613-56A5A266-8A13-4FBA-8FEA-B13EC0CFEF6E Q36020243-254578D6-1426-4257-A0BF-C1667A5C48AF Q36189372-D480EA64-7033-4AE2-915B-36F9EECD0ADE Q36288540-2C2F178B-D7C1-404B-9947-E967BD4CFB9C Q36374624-51304EAA-C94B-497E-BE0A-4AC51D55391D Q36482341-09669073-1574-4EE4-B780-1F61EF199BA0 Q36877650-33F0D752-7C24-4AB8-978E-694C3D0C4415 Q36896218-45A9A8A8-E89A-4479-8F28-65E1EB40157B Q36987646-B2C6D572-5AF4-40E7-BDF5-C20B54262100 Q37006469-5BD85149-49F9-4CA3-89DD-E4AC8B331649 Q37072783-C13F5A4C-CBA0-4EDE-AFFE-F4789BB6AEC8 Q37115121-AC80B817-742D-4DA8-9B07-A03446499E45 Q37130788-20A75A5C-C9CE-460F-8E7A-D3E223153233 Q37247483-EBE160EE-BF06-4B75-834B-370033ACB26B Q37465084-9D290E1B-FB21-44C7-9CC3-EF5595BE67F6 Q37825615-76F191A6-E153-4990-BE3F-1FC7450D667A Q38019608-419ED592-5F21-46F9-9E21-80E3E0BDBA0C Q40040767-2210C73B-5BB7-419B-A47E-7D214D46D5BD Q40171362-3913221C-76C3-4835-9697-5392DC95CFF5 Q40448851-2B812AD6-DE3F-42E5-BF52-B534BDE26A58 Q41935348-E5403068-E6A5-4FBB-B390-5C3426E8296E Q43412211-627FD8D4-138A-4313-90DB-54A3B7C1C2FE Q46735991-9B944A70-4FD7-4020-B842-5AFC05B1873C Q46748137-B0A29AED-1C57-4778-97E0-F3FF15DA6C6F Q46949637-450A013C-2190-43F3-BB5A-16748E35C961 Q48424918-D8CB33E1-3F8C-445A-B8D2-2502B57ED288 Q57940190-2568C0E3-466B-4E1D-8AA9-433FD41F412F

P2860

Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.

http://www.wikidata.org/entity/Q34078570

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@ast

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@en

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@nl

type

label

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@ast

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@en

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@nl

prefLabel

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@ast

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@en

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@nl

P1433

Q34078570-4DE0E06C-EE42-4C1E-8D06-F0FB58BD1FCB

P1476

Q34078570-72D87908-E37F-447E-A031-D3B997FEFA95

P2093

Q34078570-08AF7E4C-7AC6-435E-AB8D-F787692A441B

Q34078570-18B192E2-AA98-4D44-AD4D-7A93DA578516

Q34078570-1AB8F414-45C1-4A2E-9435-A261265FDD69

Q34078570-91DFF7F7-CF7D-406C-8316-6072F0481AC9

P2860

Q34078570-01858F31-6EED-4D29-B15F-EE172062B5A1

Q34078570-1D70AFB0-D58E-4EF8-9B75-AA820C1E68BE

Q34078570-3D76D91D-4232-4EB8-9E3E-E77090C4A515

Q34078570-42BDD303-E490-4DB5-89D6-24FE1DF3E490

Q34078570-4C9364AF-2F46-42E7-8B1A-D9D18099574E

Q34078570-6EF9AF75-7F2D-463E-B7CA-72B0518680C3

Q34078570-865D6E07-0685-40CE-A39D-57D74B31DE04

Q34078570-89021079-8E9E-42A4-9AC6-D8B3612AB901

Q34078570-8EDD5ED6-EE51-4ECE-9D1F-6C27A55592FC

Q34078570-8EEE110F-B4F7-4530-9CF8-58A31F01B41E

P304

Q34078570-2BDE4211-40E1-4660-8A80-95BCD052D10B

P31

Q34078570-B54865A9-8DFC-499E-BBB7-1FD4E171C203

P356

Q34078570-951F4424-8B37-41C4-91B0-D61D30BB54ED

P407

Q34078570-662C37B4-92C8-42A2-B087-381F94C33B05

P433

Q34078570-30960A17-81C3-473A-8767-EC07470AD637

P478

Q34078570-27CABD55-B1E8-4062-A667-20B6A403E373

P577

Q34078570-83F806CC-31A4-4638-BA34-F86F303C4ACD

P5875

Q34078570-F63B97F4-91E5-43AD-B35F-CAA9945B36A8

P698

Q34078570-22C5C707-61DF-415F-A218-F44A67F3B147

P921

Q34078570-3A2C537F-F4E3-46AE-867B-A7CD9088F7BE

P932

Q34078570-B8B599BC-89BA-469C-BBB5-F8FF85E41492

P356

PNAS.0507300102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Inhibition of hypothalamic fat ...... oxidation in skeletal muscle.

@en

P2093

M Daniel Lane

http://www.w3.org/2001/XMLSchema#string

Seung Hun Cha

http://www.w3.org/2001/XMLSchema#string

Shigeru Chohnan

http://www.w3.org/2001/XMLSchema#string

Zhiyuan Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

AMP-activated protein kinase plays a role in the control of food intake

Central nervous system control of food intake

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides.

Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice.

C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity

Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle.

Synthesis and antitumor activity of an inhibitor of fatty acid synthase.

P304

14557-14562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0507300102

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7561218

http://www.w3.org/2001/XMLSchema#string

P698

16203972

http://www.w3.org/2001/XMLSchema#string

P921

P932

1253598

http://www.w3.org/2001/XMLSchema#string